Incyte (INCY) Buildings (2018)

Incyte (INCY) reported Buildings of $37.5 million for Q4 2018.

Incyte (INCY) Buildings (2018) Analysis & Trends

Incyte has reported Buildings for 1 years, with the latest figure at $37.5 million in Q4 2018.

For the quarter ending Q4 2018, Buildings changed N/A year-over-year to $37.5 million; the trailing twelve-month figure through Dec 2018 stood at $37.5 million (changed N/A YoY), and the FY2018 full-year result was $37.5 million, changed N/A from the prior year.
Buildings for Q4 2018 stood at $37.5 million.
The five-year high for Buildings was $37.5 million in Q4 2018, with the low at $37.5 million in Q4 2018.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	Incyte	19.62 Bn	15.60 Bn	1.17 Bn

Historic Data

Download Data

Date	Value
Dec 31, 2018	37.50 Mn